| Literature DB >> 32891631 |
Franco Lombardo1, Jörg Bentzien2, Giuliano Berellini3, Ingo Muegge2.
Abstract
A novel, descriptor-parsimonious in silico model to predict human VDss (volume of distribution at steady-state) has been derived and thoroughly tested in a quasi-prospective regimen using an independent test set of 213 compounds. The model performs on par with a former benchmark model that relied on far more descriptors. As a result, the new random forest model relying on only six descriptors allows for interpretations that help chemists to design compounds with desired human VDss values. A comparison of in silico predictions of VDss with models using in vitro derived descriptors or in vivo scaling methods supports the strength of the in-silico approach, considering its resource- and animal-sparing nature. The strong performance of the in silico VDss models on structurally novel compounds supports the high degree of confidence that can be placed in using in silico human VDss predictions for compound design and human dose predictions.Entities:
Keywords: Computational ADME; Distribution; Pharmacokinetics
Mesh:
Substances:
Year: 2020 PMID: 32891631 DOI: 10.1016/j.xphs.2020.08.023
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534